Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DENTSPLY SIRONA Inc.XRAY · Entity 4448 | Chief Accounting Officer | July 08, 2022 | July 11, 2022 |
| ICF International, Inc.ICFI · Entity 740 | VP & Principal Accounting Off. | March 20, 2026 | March 24, 2026 |
| Leidos Holdings, Inc.LDOS · Entity 668 | SVP and Corporate Controller | May 13, 2019 | May 14, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DENTSPLY SIRONA Inc.
Report date July 08, 2022 · Filed July 11, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,754.524 |
Reported balance
After 2022-07-08 transaction · row 1
1 source rowRow 1 · 2022-07-08 · Grant · Acquired 8.014 · Balance 2,754.524 F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. |
| Phantom Stock (Supplemental Executive Retirement Plan) SERPSEC Table II · derivative / convertible security | Direct | 461.1335 |
Reported balance
After 2022-07-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-07-08 · Grant · Acquired 1.617 · Balance 461.1335 F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F3: Comprised of phantom stock acquired as a result of accrued dividends. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.
F3: Comprised of phantom stock acquired as a result of accrued dividends.
ICF International, Inc.
Report date March 20, 2026 · Filed March 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 258 |
Ending reported balance
After 2026-03-20 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-03-20 · Exercise / conversion · Acquired 197 · Balance 263 F1: The exercise price for the restricted stock unit exercise was $65.89. Row 2 · 2026-03-20 · Exercise / conversion · Acquired 102 · Balance 365 F1: The exercise price for the restricted stock unit exercise was $65.89. Row 3 · 2026-03-20 · Tax withholding · Disposed 37 · Balance 328 Row 4 · 2026-03-20 · Tax withholding · Disposed 70 · Balance 258 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,507 |
Reported balance
After 2026-03-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-20 · Grant · Acquired 813 · Balance 2,507 F2: Each restricted stock unit is the economic equivalent of one share of ICF International, Inc.'s Common Stock. F3: These acquired restricted stock units were granted pursuant to ICF International, Inc.'s 2018 Omnibus Incentive Plan, as amended. These restricted stock units vest over a period of three (3) years, at 25% on each of the first two anniversaries of the grant and 50% on the third anniversary from the day of grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,405 |
Reported balance
After 2026-03-20 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-20 · Exercise / conversion · Disposed 102 · Balance 2,405 F1: The exercise price for the restricted stock unit exercise was $65.89. F4: Represents the 2nd vesting anniversary (25%) of acquired restricted stock units granted pursuant to the 2018 Omnibus Incentive Plan, as amended. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,280 |
Reported balance
After 2026-03-20 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-03-20 · Exercise / conversion · Disposed 125 · Balance 2,280 F5: The market value for the cash-settled restricted stock unit exercise was $115.32. F7: The emarket value for the cash-settled restricted stock unit exercise was $115.32. F6: Represents the second vesting anniversary (25%) of acquired cash-settled restricted stock units granted pursuant to the 2010 Omnibus Plan, as amended. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,083 |
Reported balance
After 2026-03-20 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-03-20 · Exercise / conversion · Disposed 197 · Balance 2,083 F1: The exercise price for the restricted stock unit exercise was $65.89. F8: Represents the 1st vesting anniversary (25%) of acquired restricted stock units granted pursuant to the 2018 Omnibus Incentive Plan, as amended. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,849 |
Reported balance
After 2026-03-20 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-03-20 · Exercise / conversion · Disposed 234 · Balance 1,849 F9: The market value for the cash-settled restricted stock unit exercise was $80.08. F10: Represents the third vesting anniversary (50%) of acquired cash-settled restricted stock units granted pursuant to the 2010 Omnibus Plan, as amended. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,609 |
Reported balance
After 2026-03-20 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-03-20 · Exercise / conversion · Disposed 240 · Balance 1,609 F11: The exmarket value for the cash-settled restricted stock unit exercise was $66.62. F13: The market value for the cash-settled restricted stock unit exercise was $66.62. F12: Represents the first vesting anniversary (25%) of acquired cash-settled restricted stock units granted pursuant to the 2010 Omnibus Plan, as amended. |
Filing footnotes · ownership attribution and instrument terms
F1: The exercise price for the restricted stock unit exercise was $65.89.
F2: Each restricted stock unit is the economic equivalent of one share of ICF International, Inc.'s Common Stock.
F3: These acquired restricted stock units were granted pursuant to ICF International, Inc.'s 2018 Omnibus Incentive Plan, as amended. These restricted stock units vest over a period of three (3) years, at 25% on each of the first two anniversaries of the grant and 50% on the third anniversary from the day of grant.
F4: Represents the 2nd vesting anniversary (25%) of acquired restricted stock units granted pursuant to the 2018 Omnibus Incentive Plan, as amended.
F5: The market value for the cash-settled restricted stock unit exercise was $115.32.
F6: Represents the second vesting anniversary (25%) of acquired cash-settled restricted stock units granted pursuant to the 2010 Omnibus Plan, as amended.
F7: The emarket value for the cash-settled restricted stock unit exercise was $115.32.
F8: Represents the 1st vesting anniversary (25%) of acquired restricted stock units granted pursuant to the 2018 Omnibus Incentive Plan, as amended.
F9: The market value for the cash-settled restricted stock unit exercise was $80.08.
F10: Represents the third vesting anniversary (50%) of acquired cash-settled restricted stock units granted pursuant to the 2010 Omnibus Plan, as amended.
F11: The exmarket value for the cash-settled restricted stock unit exercise was $66.62.
F12: Represents the first vesting anniversary (25%) of acquired cash-settled restricted stock units granted pursuant to the 2010 Omnibus Plan, as amended.
F13: The market value for the cash-settled restricted stock unit exercise was $66.62.
Leidos Holdings, Inc.
Report date May 13, 2019 · Filed May 14, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,146.728 |
Reported balance
After 2019-05-13 transaction · row 1
1 source rowRow 1 · 2019-05-13 · Tax withholding · Disposed 58 · Balance 6,146.728 F1: Reporting shares withheld for taxes from the vesting of previously issued restricted share unit awards. |
Filing footnotes · ownership attribution and instrument terms
F1: Reporting shares withheld for taxes from the vesting of previously issued restricted share unit awards.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2017 Filed May 16, 2017 18:35 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Tax withholdingCommon Stock | 63 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-009934 · doc4.xml · nonDerivative · entry 1 Chadha Ranjit S · CIK 0001672529 · SVP and Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,497 F1 · shares: Reporting shares withheld for taxes from previously issued restricted share unit awards. Read SEC document |
| March 04, 2017 Filed Mar 7, 2017 18:42 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Tax withholdingCommon Stock | 44 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-005789 · doc4.xml · nonDerivative · entry 1 Chadha Ranjit S · CIK 0001672529 · SVP and Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,560 F1 · shares: Reporting shares withheld for taxes from previously issued restricted share unit awards. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 18:42 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | GrantStock Option (Right to Buy) · Derivative | 4,420 | $0.00 Strike: $53.54 | $0.00 |
DisclosureSEC source: 0001225208-17-005789 · doc4.xml · derivative · entry 2 Chadha Ranjit S · CIK 0001672529 · SVP and Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,420 Underlying: Common Stock · 4,420 shares Expires 2024-03-02 F2 · shares: The option award vests in four equal annual installments beginning on March 3, 2018. Read SEC document |
| December 11, 2016 Filed Dec 13, 2016 17:48 UTC | Leidos Holdings, Inc. LDOS · Entity 668 | Tax withholdingCommon Stock | 109 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-043107 · doc4.xml · nonDerivative · entry 1 Chadha Ranjit S · CIK 0001672529 · SVP and Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,604 F1 · shares: Reporting shares withheld for taxes resulting from the vesting of previously issued restricted share unit awards. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.